91 related articles for article (PubMed ID: 21640077)
21. Prolyl-isomerase Pin1 impairs trastuzumab sensitivity by up-regulating fatty acid synthase expression.
Yun HJ; Kim JY; Kim G; Choi HS
Anticancer Res; 2014 Mar; 34(3):1409-16. PubMed ID: 24596388
[TBL] [Abstract][Full Text] [Related]
22. PIN1 expression contributes to hepatic carcinogenesis.
Pang RW; Lee TK; Man K; Poon RT; Fan ST; Kwong YL; Tse E
J Pathol; 2006 Sep; 210(1):19-25. PubMed ID: 16841372
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-34-CSF1R Signaling Axis Promotes Epithelial Cell Transformation and Breast Tumorigenesis.
Poudel M; Kim G; Bhattarai PY; Kim JY; Choi HS
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800170
[TBL] [Abstract][Full Text] [Related]
24. [Pin1: a multi-talented peptidyl prolyl cis-trans isomerase and a promising therapeutic target for human cancers].
Marsolier J; Weitzman JB
Med Sci (Paris); 2014; 30(8-9):772-8. PubMed ID: 25174754
[TBL] [Abstract][Full Text] [Related]
25. Pin1 is overexpressed in oral squamous cell carcinoma and its levels correlate with cyclin D1 overexpression.
Miyashita H; Mori S; Motegi K; Fukumoto M; Uchida T
Oncol Rep; 2003; 10(2):455-61. PubMed ID: 12579289
[TBL] [Abstract][Full Text] [Related]
26. The peptidyl-prolyl isomerase Pin1 regulates cytokinesis through Cep55.
van der Horst A; Khanna KK
Cancer Res; 2009 Aug; 69(16):6651-9. PubMed ID: 19638580
[TBL] [Abstract][Full Text] [Related]
27. Prolyl isomerase Pin1 expression predicts prognosis in patients with esophageal squamous cell carcinoma and correlates with cyclinD1 expression.
Fukuchi M; Fukai Y; Kimura H; Sohda M; Miyazaki T; Nakajima M; Masuda N; Tsukada K; Kato H; Kuwano H
Int J Oncol; 2006 Aug; 29(2):329-34. PubMed ID: 16820873
[TBL] [Abstract][Full Text] [Related]
28. Pin1 as an anticancer drug target.
Xu GG; Etzkorn FA
Drug News Perspect; 2009 Sep; 22(7):399-407. PubMed ID: 19890497
[TBL] [Abstract][Full Text] [Related]
29. Cyclin D1 overexpression in thyroid tumours from a radio-contaminated area and its correlation with Pin1 and aberrant beta-catenin expression.
Nakashima M; Meirmanov S; Naruke Y; Kondo H; Saenko V; Rogounovitch T; Shimizu-Yoshida Y; Takamura N; Namba H; Ito M; Abrosimov A; Lushnikov E; Roumiantsev P; Tsyb A; Yamashita S; Sekine I
J Pathol; 2004 Apr; 202(4):446-55. PubMed ID: 15095272
[TBL] [Abstract][Full Text] [Related]
30. Epigallocatechin-gallate suppresses tumorigenesis by directly targeting Pin1.
Urusova DV; Shim JH; Kim DJ; Jung SK; Zykova TA; Carper A; Bode AM; Dong Z
Cancer Prev Res (Phila); 2011 Sep; 4(9):1366-77. PubMed ID: 21750208
[TBL] [Abstract][Full Text] [Related]
31. Pin1 gene mutation is a rare event in gastric cancer.
Kim CJ; Song JH; Cho YG; Chae HS; Nam SW; Yoo NJ; Lee JY; Park WS
APMIS; 2006; 114(7-8):518-22. PubMed ID: 16907857
[TBL] [Abstract][Full Text] [Related]
32. Expression and significance of Pin1, β-catenin and cyclin D1 in hepatocellular carcinoma.
Ao R; Zhang DR; Du YQ; Wang Y
Mol Med Rep; 2014 Oct; 10(4):1893-8. PubMed ID: 25109821
[TBL] [Abstract][Full Text] [Related]
33. Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells.
Khanal P; Yun HJ; Lim SC; Ahn SG; Yoon HE; Kang KW; Hong R; Choi HS
Oncogene; 2012 Aug; 31(34):3845-56. PubMed ID: 22158035
[TBL] [Abstract][Full Text] [Related]
34. Prevalent overexpression of prolyl isomerase Pin1 in human cancers.
Bao L; Kimzey A; Sauter G; Sowadski JM; Lu KP; Wang DG
Am J Pathol; 2004 May; 164(5):1727-37. PubMed ID: 15111319
[TBL] [Abstract][Full Text] [Related]
35. Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes.
Liou YC; Ryo A; Huang HK; Lu PJ; Bronson R; Fujimori F; Uchida T; Hunter T; Lu KP
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1335-40. PubMed ID: 11805292
[TBL] [Abstract][Full Text] [Related]
36. Ochratoxin A-induced cell proliferation and tumor promotion in mouse skin by activating the expression of cyclin-D1 and cyclooxygenase-2 through nuclear factor-kappa B and activator protein-1.
Kumar R; Alam S; Chaudhari BP; Dwivedi PD; Jain SK; Ansari KM; Das M
Carcinogenesis; 2013 Mar; 34(3):647-57. PubMed ID: 23172667
[TBL] [Abstract][Full Text] [Related]
37. Pin1 induction in the fibrotic liver and its roles in TGF-β1 expression and Smad2/3 phosphorylation.
Yang JW; Hien TT; Lim SC; Jun DW; Choi HS; Yoon JH; Cho IJ; Kang KW
J Hepatol; 2014 Jun; 60(6):1235-41. PubMed ID: 24530597
[TBL] [Abstract][Full Text] [Related]
38. Peptidylprolyl cis/trans isomerase, NIMA-interacting 1 (PIN1) regulates pulmonary effects of endotoxin and tumor necrosis factor-α in mice.
Liu T; Schneider RA; Lee NY; Hoyt DG
Biochem Biophys Res Commun; 2014 Sep; 452(3):468-72. PubMed ID: 25159840
[TBL] [Abstract][Full Text] [Related]
39. Pin1 regulates centrosome duplication, and its overexpression induces centrosome amplification, chromosome instability, and oncogenesis.
Suizu F; Ryo A; Wulf G; Lim J; Lu KP
Mol Cell Biol; 2006 Feb; 26(4):1463-79. PubMed ID: 16449657
[TBL] [Abstract][Full Text] [Related]
40. Stable suppression of tumorigenicity by Pin1-targeted RNA interference in prostate cancer.
Ryo A; Uemura H; Ishiguro H; Saitoh T; Yamaguchi A; Perrem K; Kubota Y; Lu KP; Aoki I
Clin Cancer Res; 2005 Oct; 11(20):7523-31. PubMed ID: 16243827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
